ADBiotech Co

ADBiotech Co FCF Growth

The Year-over-Year Free Cash Flow Growth of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 60.42 %. In the previous year, Year-over-Year Free Cash Flow Growth was -17,222.05 % — a change of -100.35% (higher).

FCF Growth

60.42 %

YoY

-100.35%

Last updated:

Year-over-Year Free Cash Flow Growth of ADBiotech Co is 2025 60.42 % . Year-over-Year Free Cash Flow Growth of ADBiotech Co was 2024 -17,222.05 % . It decreases by -100.35% higher compared to the previous year.

The ADBiotech Co FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2018
-29.43 KRW
Jan 1, 2019
92.56 KRW
Jan 1, 2020
-3,632.72 KRW
Jan 1, 2021
9.29 KRW
Jan 1, 2022
-62.85 KRW
Jan 1, 2023
100.27 KRW
Jan 1, 2024
-17,222.05 KRW
Jan 1, 2025
60.42 KRW
The ADBiotech Co FCF Growth history
YEARFCF GrowthYoY
60.42 %-100.35%
-17,222.05 %-17,275.92%
100.27 %-259.55%
-62.85 %-776.78%
9.29 %-100.26%
-3,632.72 %-4,024.60%
92.56 %-414.48%
-29.43 %-41.53%
-50.34 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Year-over-Year Free Cash Flow Growth of ADBiotech Co is 60.42 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's ADBiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — ADBiotech Co

All Key Metrics — ADBiotech Co